| With the new healthcare reform policy and the implement of the development Plan for the pharmaceutical circulation industry, domestic pharmaceutical market appear competitive and complicated situation. Trans regional, cross industry merger and reorganization of the further acceleration, "stronger, bigger, to do better" is the theme of the development of pharmaceutical industry in the next period of time. At the same time, Sinopharm holding the reorganization of the Sichuan Medicine Group Ltd.. In this critical moment, so how to respond to the challenge of rival after transformation, how to enhance the competitive advantage and build up their core competitiveness is the urgent need to address the strategic issues for Sichuan Medicine Group Ltd..The article is divided into seven parts, including introduction, general situation and restructuring background of Sichuan Medicine Group Ltd, Environmental analysis of Sichuan Medicine Group Ltd., opportunities and challenges of Sichuan Medicine Group Ltd. on Sinopharm, the strategic positioning and development priorities of Sichuan Medicine Group Ltd. under Sinopharm, development strategy implementation and countermeasures of Sichuan Medicine Group Ltd. under Sinopharm and conclusion. The first part of the thesis is mainly on the research background and significance to do the analysis, and this paper introduces the main content and the train of thought of the thesis; The second part of the paper introduces in detail the general situation and the restructuring background of Sichuan Medicine Group Ltd. The third part of the paper used PEST method, introduces the development environment of domestic pharmaceutical industry; secondly, to do some analysis and comparison on the development environment about home and abroad pharmaceutical industry, points out the problems the pharmaceutical industry of our country; finally, according to the medical market of Sichuan, Sichuan Medicine Group Ltd. is analyzed and the details of the overall environment, and points out that the development of the company’s advantages and disadvantages; The fourth part of the paper is about after the Chinese Medicine Group Holdings, this paper expounds in detail the development opportunities to bring our company; at the same time to predict possible challenges and risk brought about by changes in the market; The fifth part of the thesis, is to do a detailed theory and practice analysis of strategic direction of the development, key links and the implementation of the strategy after the reorganization of the company; The sixth part of the paper, from five aspects of enterprise, such as the adjustment of organizational structure, adjustment of resources integration, the network channel adjustment, extend the industrial adjustment, enterprise brand adjustment, describes the development strategy and implementation plan of Sichuan Medicine Group Ltd. under Sinopharm, and on this basis puts forward certain proposals; The seventh part is the conclusion, summarizes the full thesis.In this paper, the main has done some research about development strategy for Sichuan Medicine Group Ltd. under Sinopharm, and did a detailed theory and practice analysis of strategic direction of the development, key links and the implementation of the strategy after the reorganization of the company, and put forward the measures and suggestions. From the case of merger and reorganization of the central state-owned enterprises and the provincial state-owned enterprises, to deepen the reform of state-owned property right system makes a theoretical exploration. Can be referred by the other medicine circulation enterprises, and also have certain reference value for the development of our country medicine industry. |
PDF Full Text Request